Multifunctionalized Reduced Graphene Oxide Biosensors for Simultaneous Monitoring of Structural Changes in Amyloid-β 40

Sensors
Dahye JeongKyo Seon Hwang

Abstract

Determination of the conformation (monomer, oligomer, or fibril) of amyloid peptide aggregates in the human brain is essential for the diagnosis and treatment of Alzheimer's disease (AD). Accordingly, systematic investigation of amyloid conformation using analytical tools is essential for precisely quantifying the relative amounts of the three conformations of amyloid peptide. Here, we developed a reduced graphene oxide (rGO) based multiplexing biosensor that could be used to monitor the relative amounts of the three conformations of various amyloid-β 40 (Aβ40) fluids. The electrical rGO biosensor was composed of a multichannel sensor array capable of individual detection of monomers, oligomers, and fibrils in a single amyloid fluid sample. From the performance test of each sensor, we showed that this method had good analytical sensitivity (1 pg/mL) and a fairly wide dynamic range (1 pg/mL to 10 ng/mL) for each conformation of Aβ40. To verify whether the rGO biosensor could be used to evaluate the relative amounts of the three conformations, various amyloid solutions (monomeric Aβ40, aggregated Aβ40, and disaggregated Aβ40 solutions) were employed. Notably, different trends in the relative amounts of the three conformations wer...Continue Reading

References

Oct 13, 1995·The Journal of Biological Chemistry·C J PikeC W Cotman
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yuesong GongWilliam L Klein
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Nov 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Anant K ParavastuRobert Tycko
May 16, 2009·Chemistry : a European Journal·Ming ZhouShaojun Dong
Sep 22, 2010·Neuropsychiatric Disease and Treatment·Weiming Xia
Feb 27, 2015·Alzheimer's Research & Therapy·Yannick VermeirenPeter P De Deyn
Jun 28, 2016·Scientific Reports·Marija IljinaDavid Klenerman
Nov 20, 2016·EMBO Molecular Medicine·Seung-Hoon YangYoungSoo Kim
Jul 29, 2017·Acta neurologica Belgica·Ellis NiemantsverdrietSebastiaan Engelborghs

❮ Previous
Next ❯

Methods Mentioned

BETA
biosensor
biosensors
atomic force microscopy
transmission electron microscopy
AFM

Software Mentioned

NanoScope Analysis

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

© 2022 Meta ULC. All rights reserved